May 10 |
ACADIA Pharmaceuticals Q1 2024 Earnings: Solid Growth with New Product Launches
|
May 10 |
ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
May 9 |
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
|
May 9 |
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
|
May 9 |
ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...
|
May 9 |
ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
|
May 9 |
ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
|
May 8 |
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
|
May 8 |
Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M
|
May 8 |
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
|